Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) plummeted -2.28 percent and ended the day at $5.57. The Average Volume of the company is 6.9 Million and P/E (price to earnings) ratio is 0, while Forward P/E ratio is 0.

Oppenheimer Initiated its coverage for Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) in a note sent to investors on 5-Jan-17. The research firm Initiated the stock to Outperform. Moreover, Citigroup issued Downgrade rating for the stock on 18-Dec-15. Canaccord Genuity also Initiated the company to Buy on 22-May-15, 2016. Additionally, Cantor Fitzgerald Initiated its ratings on the stock to Buy.

The highest price SGYP stock touched in the last 12 month was $7.15 and the lowest price it hit in the same period was $2.5. The stock has a Return on Assets of -182 percent, Return on Investment of 0 percent and a Return on Equity of -876.7 percent. The company’s market cap is $1.11 Billion.

Price Target is an important factor while doing analysis of a stock. According to 6 analysts, Price Target for Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) may hit a high of $18. The average and low price target for the stock are $11.5 and $6.5, respectively.

Now we look at the Moving Averages, the 200-day is 11.15, the 50-day is -8.26 and the 20-day is -6.67. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.

When we look at the recommendation trends, the stock presently has an average brokerage recommendation of 1.2. Out of 6 brokerage recommendations, 3 gave a Strong Buy, 2 issued a Buy, 1 issued Hold, 0 rated Under-perform and 0 issued a Sell.

Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) performance during the last one year Improved 60.52 percent, while its year to date (YTD) performance showed a Negative trend of -8.54 percent. The stock Jumped 17.02 percent over the past six months. The stock’s quarterly performance indicates a Positive momentum of 9 percent, whereas its last one month trend is Pessimistic with -12.15 percent. Its weekly performance showed downward trend of -5.91 percent.

Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at 0 percent, operating profit margin was 0 percent, whereas gross profit margin stands at 0 percent. Beta factor was calculated at 1.55.

Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) has 169.54 Million shares outstanding and 128.92 Million shares were floated in market. The short ratio in the company’s stock is documented at 5.58 and the short float is around of 29.87%. The stock’s average true range of stands at 0.35, while the relative strength index is 41.73.

Liquidity ratios helps investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 2.8, current ratio was 3, LT Debt/Equity ratio was 0.61 and Total Debt/Equity ratio was 0.61.